UPDATE: JPMorgan Downgrades Atea Pharmaceuticals (AVIR) to Neutral
Tweet Send to a Friend
(Updated - October 20, 2021 3:50 AM EDT)
JPMorgan analyst Eric Joseph downgraded Atea Pharmaceuticals (NASDAQ: AVIR) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Eric Joseph downgraded Atea Pharmaceuticals (NASDAQ: AVIR) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE